Christopher Fiore (Chris Fiore)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Transcription Factor

Randomized Controlled Trial

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Science translational medicine

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Mudit Chaand, Christopher Fiore, Brian Johnston, Anthony D'Ippolito, Diane H Moon, John P Carulli, Jeffrey R Shearstone
Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor. Communications biology 6 (1) (2023)
Stéphane de Botton, Thomas Cluzeau, Carlos Enrique Vigil, Rachel Cook, Philippe Rousselot, David A Rizzieri, Jane L Liesveld, Pierre Fenaux, Thorsten Braun, Anne Banos, Joseph G Jurcic, Mikkael A Sekeres, Michael R Savona, Gail J Roboz, Dale Bixby, Kate Madigan, Angela Volkert, Kristin Stephens, Qing Kang-Fortner, Kristen Baker, Sofia Paul, Michael Robert McKeown, John P Carulli, Matthew Lucas Eaton, Graeme Hodgson, Christopher Fiore, Michael Kelly, David A Roth, Eytan M Stein
Targeting RARA Overexpression with Tamibarotene, a Potent and Selective RARα Agonist, is a Novel Approach in AML. Blood advances (2022)
Marie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, Sandra Martínez-Martín, Peter Rahl, Loïka Maltais, Mariano F Zacarias-Fluck, Sílvia Casacuberta-Serra, Erika Serrano Del Pozo, Christopher Fiore, Laia Foradada, Virginia Castillo Cano, Meritxell Sánchez-Hervás, Matthew Guenther, Eduardo Romero Sanz, Marta Oteo, Cynthia Tremblay, Génesis Martín, Danny Letourneau, Martin Montagne, Miguel Ángel Morcillo Alonso, Jonathan R Whitfield, Pierre Lavigne, Laura Soucek
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy. Science translational medicine 11 (484) (2020)